All veterinary surgeons, veterinary nurses and VN students are to be invited to take part in an RCVS survey of their profession and, for the first time, these surveys will measure mental wellbeing at a population level.RCVS Registrar, Jane Hern said: "Both surveys are being undertaken on our behalf by the Institute of Employment Studies - an independent research organisation. As in previous surveys, all the data will be anonymised by the IES before being shared with us. This will ensure individuals cannot be identified."The information will provide a snapshot of the veterinary profession and help the RCVS to understand and analyse changing trends. Some of the anonymised data will also be shared with researchers at Defra and at the School of Medicine, University of Southampton, who will analyse selected topics in more depth.Jane added: "These surveys produce very useful information about the veterinary and veterinary nursing profession, not least because they usually get a good response rate.
"We will use the information, for example, in our discussions about new veterinary legislation, 24/7 and the Professional Development Phase for newly-qualified vets. So please make sure that you send the form to the IES - or fill it in online - before 8 February."The RCVS normally surveys veterinary surgeons every four years, and last surveyed veterinary nurses in 2008. To obtain concurrent data regarding vets and VNs, both these surveys are taking place at the same time. Forms can by sent back in the freepost envelope provided, or completed online at www.employmentresearch.co.uk/vs2010.htm (vets) and www.employmentresearch.co.uk/vn2010.htm (VNs). The findings of previous studies can be found at www.rcvs.org.uk/surveys.
Dorwest Herbs has highlighted research that suggests a highly rational mode of action for kelp seaweed as an aid in the treatment of obesity when used alongside a weight reduction diet. The company is asking vets and nurses to look at the evidence and consider using licensed herbal medicines to help cats and dogs lose weight naturally. To help you evaluate the product, Dorwest is giving away 50 trial packs of Kelp Seaweed Tablets.
Mary Boughton MBE, Quality Director at Dorwest Herbs and the UK's leading specialist in the formulation of veterinary herbal medicines said: "We have lots of evidence that Kelp Seaweed Tablets work as an aid in the treatment of obesity but traditional explanations were based on the effect of iodine supplementation on thyroid function as a mode of action. That just didn't hold water for us. However, in common with many conventional medicines, the mechanisms for mode of action of herbal medicines are often not known. So, it was with some excitement that we heard of research that demonstrated that fucoxanthin, a pigment found in kelp, upregulates expression of UCP1 (uncoupling protein) and produces weight loss in the same region as conventional anti-obesity drugs."
Various studies estimate pet obesity may affect 30 to 60 per cent of pets in the UK and arthritis, heart disease and diabetes are just some of the diseases that occur with increasing frequency in obese pets. The research indicates that fucoxanthin has an effect on glucose metabolism and may lower the risk of coronary heart disease in humans. Phlorotannins found in brown seaweed have also recently been indentified as interfering with both the onset and consequences of osteoarthritis. Mary Boughton points out that multiple effects are often seen when herbal treatments are used, "Herbal treatments contain thousands of plant derived chemical compounds and are known for their diverse action, as opposed to the 'magic bullet' effect seen with conventional medicines. In a condition such as obesity where we see many disruptions of normal metabolism and several co-morbid conditions, choosing a herbal treatment makes sense. Kelp Seaweed Tablets are the logical alternative."
Dorwest has prepared a fully referenced technical information sheet detailing recent scientific studies and data from herbal formularies with reference to the role of kelp seaweed in obesity management.
To help vets and nurses further evaluate Kelp Seaweed Tablets - a licensed herbal medicine - used as part of a weight management programme the company is giving away 50 FREE trial packs containing seven weeks of Kelp Seaweed Tablets for a large breed dog, a case report sheet and the technical information sheet. There is also a prize of £100 of John Lewis shopping vouchers for the most informative case report received before the end of February 2010. There is one pack available per practice, while stocks last.
To request a technical information sheet or pack call Dorwest Herbs on 01308 897272.
Genitrix is offering a free poster-sized treatment and dispensing guide for small animals. Designed to be pinned on the consulting room or dispensary wall, the poster sets out key data, including active ingredients, species information and application advice for the company's range of anti-parasite treatments for rabbits, ferrets, rodents, reptiles, birds and other exotic pets.
These include the ivermectin-based Xeno topical spot-on and spray range; Xenex Ultra, the permethrin-based topical spot-on preventive treatment for flystrike; Lapizole, a fenbendazole-based oral treatment for E.cuniculi and Mycozole, a miconazole-based spray for fungal infections, including ringworm.
Rob Watkins, Marketing Director at Genitrix, said: "The treatment guide provides easy to use and clear information on all our small animal products and their use for the practice team."
To request a free poster, please contact Genitrix on 01403 786345 or by email to mail@genitrix.co.uk
A Dogs Trust Glasgow resident who made the news last January for being so obese he could not even walk has lost almost half his body weight.
Patch, a six year old Beagle Cross, weighed the same as an average six year old child - 4.5 stones (28.45kg) - when he was brought to the Rehoming Centre last year.
Staff desperately hoped 2009 would see him find a new home and see him shed almost half his bodyweight to reach his goal of 2.4 stone (15kg). After finding a new home with the MacLean family in Motherwell, exactly one year after hitting the headlines Patch is within sniffing distance of his target by weighing in at 2.9 stone (18kg).
Vets had warned that a rapid weight loss would put strain on Patch's organs and could actually harm him, so it has been a slow, careful process. He follows a strict diet and his exercise levels have been built up gradually, with careful monitoring by veterinary staff.
Claire Kelman, Dogs Trust Glasgow Assistant Centre Manager, said: "When Patch first came to us he was so obese he couldn't even walk and needed a sling to be moved from one place to another. Now he's lost the weight he can run around and properly enjoy his walks like any other dog.
It just goes to show a good diet and careful exercise can make a real impact, so maybe he can be a shining example for everyone feeling a bit bloated after the Christmas break!"
Images courtesy Centre Press Agency
Janssen Animal Health has announced that it has acquired the distribution rights for a range of sedatives and anaesthetics for small and large animals, including Dexdomitor, Domitor and Antisedan.
Janssen aquired the marketing and distribution rights, which were previously held by Pfizer Inc, from Orion Corporation.
Dr. Enno Gottschalk , Janssen's European Director Marketing and Sales said: "This acquisition of distribution rights results in the perfect combination of proven and effective products with the outstanding service and technical selling capabilities of Janssen Animal Health. The products include the sedative Dexdomitor and Domitor, as well as the antagonist Antisedan. Among large animals, predominantly horses, the sedative injection Domosedan is now on offer as part of the Janssen Animal Health portfolio."
The Kennel Club has broadly welcomed Professor Sir Patrick Bateson's 'Independent Inquiry into Dog Breeding', which has recommended that steps be taken to tackle irresponsible breeders and to change the way the public think about buying dogs.
The Kennel Club, which commissioned and funded the report in conjunction with Dogs Trust, welcomes the report's focus on irresponsible breeders who farm puppies with little concern for their welfare and those who sell poorly socialised puppies on to owners to use as 'status dogs' or as fighting weapons.
The Kennel Club agrees that additional training and support needs to be given to local authorities, which are responsible for issuing breeding licences to those people who breed five or more litters of puppies in a single year, as the current provisions are deemed to be ineffective. It agrees that compulsory microchipping of dogs and increased public education to stop people falling prey to puppy farmers and to help them find responsible breeders are necessary.
It is also glad that the report recognises the need for a 'robustly policed and well respected quality assurance scheme', consisting of breeders that buyers can trust to look after their puppies' health and welfare, and that it suggests that the Kennel Club's Accredited Breeder Scheme, with some modification could be used.
However, the Kennel Club is concerned that the report could have gone further and that its recommendations do not appear directly to cover those breeders who breed less than five litters per year and who are not part of the Kennel Club Accredited Breeder Scheme. The Kennel Club would have liked to have seen a recommendation for regulation to ensure that these breeders follow higher standards, such as compulsory health testing.
Caroline Kisko, Kennel Club spokesperson, said: "Whilst the report recognises that the majority of breeders are responsible, there are those whose actions are bringing the rest of the dog breeding community into disrepute and this needs to be stopped.
"We are glad that the report recognises that the Kennel Club has made a good start in its efforts to unite responsible breeders within its Accredited Breeder Scheme, for the benefit of puppies and puppy buyers, and we believe that this should be the basis for moving forward. We are currently working towards UKAS accreditation of the scheme as suggested by Professor Bateson.
"We agree that responsible breeders should be rewarded and believe that the show ring is the best forum for this. The report recognises that 'dog showing and judging are a powerful lever for change' and the Kennel Club is dedicated to ensuring that only the healthiest dogs are rewarded at shows.
"Public education is vital and all dog welfare organisations must continue to work together to ensure that people know what to look for when buying a dog."
The report looks at genetic diversity in breeds and recognises that the Kennel Club has banned close matings. It advises that future decisions about matings that could affect genetic diversity should be 'breed specific' and made upon evidence based scientific information and advice. To this end it is recommended that the veterinary profession should gather data to show the prevalence of certain diseases and that an advisory council should develop evidence based breeding strategies.
Mrs Kisko continued: "The Kennel Club has long recognised that genetic diversity plays a crucial role in safeguarding the health of dogs and the report is absolutely right to suggest that there are no further blanket rules in place but that decisions are based upon scientific knowledge and are made on a breed by breed basis. This is why we are well on the way to creating a new database which will revolutionise the way that we record dog health data. The data will enable us to bring out our Mate Select programme, which will help breeders to find suitable mating pairs which are most likely to produce healthy offspring. The database will go further than the report's recommendation, as the data will be attributable to specific dogs, rather than being anonymous, and will give us a better picture of the health of pedigrees and crossbreeds. Such knowledge is critical and will enable us to provide information to breeders, vets, geneticists and ultimately the puppy buyer.
"We are keen to harness as much knowledge as possible for the benefit of dogs so we welcome the principle of an advisory council whose members will work with the Kennel Club to advise on decisions about breeding and health. A structure already exists in the form of the Kennel Club's Dog Health Group with its recently extended remit. Additional independent experts include canine and human geneticists, veterinary surgeons and an epidemiologist. Using this framework for establishing the advisory council under an independent chairman would save significant sums of money, which can instead be devoted entirely to the dog health research that the report identified as being in 'urgent' need of more funding."
The Kennel Club and Dogs Trust will now arrange a meeting between all relevant parties in order to move forward with the recommendations from all three reports.
The full report may be downloaded at www.dogbreedinginquiry.com
Intervet / Schering-Plough Animal Health is running a challenge over the next few months to encourage the early diagnosis of Keratoconjunctivitis sicca (KCS), a painful disease which leads to permanent blindness (see right).
Practices are being asked to perform a Schirmer Tear Test (STT) on 50 dogs not previously diagnosed with KCS for the chance to win one of 70 Samsung digital cameras.
Recent studies¹ have shown the incidence of KCS to be 4.6% of the UK dog population, rising to 8.3% in predisposed breeds. However, 20 veterinary practices have recently participated in an Early Diagnosis Programme and the number confirmed with KCS was 9.7%². 17 of the cases diagnosed had Schirmer Tear Test readings of zero.
KCS is thought to be under-diagnosed because not all cases have the classic 'textbook' appearance but look surprisingly normal despite severely reduced tear production. In addition, diagnosis usually requires clinical suspicion and a Schirmer Tear Test.
Claudia Hartley, BVSc CertVOphthal DipECVO MRCVS, European Specialist in Veterinary Ophthalmology believes that: "All sore eyes (except where a descemetocoele is present) should have a Schirmer Tear Test, whether or not there is corneal change."
Melanie Dass MA VetMB CertSAM MRCVS ACIM, Product Manager for Optimmune said: "The results of our Early Diagnosis Programme made interesting reading and supported what we have always suspected - that KCS is under-diagnosed. It's really important that dogs suffering from this disease are detected promptly as early diagnosis and treatment with Optimmune gives the best prognosis.
"As part of the Early Diagnosis Programme owners of predisposed breeds received a personalised mailing offering them a free Schirmer Tear Test and some practices also elected to test all breeds at routine consultations such as vaccination. The tests were generally performed by veterinary nurses after they had received training, with the diagnosis made by a veterinary surgeon."
For more information about KCS, Optimmune and support in implementing an Early Diagnosis Programme, please contact your local Intervet / Schering-Plough Animal Health Territory Manager or call 01908 685685.
References¹ Pierce V & Williams D, 2006. Determination of Schirmer Tear Tests values in 1000 dogs. BSAVA Abstract 2006.² Intervet / Schering-Plough Animal Health Practices Study 2009
The Animal Health Trust has announced a research project which aims to improve the way dogs are treated for cancer. As part of the project, the charity is appealing to veterinary practices to send samples taken from dogs diagnosed with cancer.
Using the samples, the AHT's Oncology Research Group aims to develop prognostic tests for a number of canine cancers. These tests will assist veterinary professionals in predicting how individual tumours will behave and respond to treatment. It means that each dog will be offered the best treatment for its individual case, ensuring that dogs which do not require aggressive therapy are spared the rigours and possible side effects associated with such a treatment.
The samples required are surplus small pieces of the biopsies of suspected tumours, collected for diagnostic histopathology. Cheek swabs, or blood samples that are surplus to those that are often collected for standard clinical investigations are also required. Samples will be submitted for research only with the written consent of each dog owner.
Mike Starkey, from the AHT's Oncology Research Group, said: "To make progress we need to collect many samples of many different tumours. We simply need vets to send us freshly frozen (not fixed in formalin) biopsies of suspected tumours."
Samples of the following tumour types are needed from the following breeds:
Sue Murphy, the AHT's Head of Oncology, said: "We know cancer is a major cause of death in dogs. The research we are doing here will arm us all with the ability to make better informed decisions about the right course of treatment for each patient."
The samples will also aid with the AHT's research into inherited genetic defects. Researchers are investigating to find out why certain pedigree dogs have an increased risk of developing a specific cancer. The AHT is part of a European research group working on the 'LUPA project' which aims to develop DNA tests to identify dogs which carry the mutations. This should enable breeders to alter their breeding strategies to reduce the incidence of dogs affected by those cancers. It will also allow vets to carefully monitor dogs who have an increased risk of developing cancer.
Mike Starkey added: "The help from veterinary practices and dog owners is invaluable in this research. Without the samples we're unable to progress our work."
If you would like further information about the project, please contact Mike Starkey on 01638 555603 or email mike.starkey@aht.org.uk
CPC, the pet crematorium, has developed a new online survey tool to help practice staff analyse the effectiveness of their bereavement care capabilities.
Called "Bereavement Care - How does your practice compare?", the online survey comprises a series of multiple choice questions designed to produce a star rating out of 5. The idea is that these questions will help practices establish whether they need to improve how staff deal with bereaved pet owners.
Duncan Francis, Director, CPC said: "Coping with the loss of a much-loved pet is never easy for a bereaved owner. While support from those who are close to both the owner and the pet can make a real difference, many vets and vet nurses have received little training on this sensitive topic.
"Understanding client's needs before, during and after euthanasia, helps staff establish a rapport with emotional clients at a critical time and maintains a positive practice image.
"The aim of the survey is to raise awareness among vets and vet nurses of the importance of feeling confident in their ability to help bereaved owners through their grief. This helps clients come to terms with the death of their pet enabling them to move on and welcome another companion animal into their lives."
To find out more about how CPC can help your practice to improve its bereavement care, please ring 01763 207700, email info@cpccares.com or visit www.cpcvets.com
The parasitologist Maggie Fisher is coordinating a survey across the UK on behalf of Bayer Healthcare, to test the efficacy of their flea treatment 'Advantage'.
She is looking to enlist some new practices to help her collect field strains of flea eggs in return for payment of £40 per sample.
If you are regularly seeing flea ridden cats or dogs and could help collect one or more samples of flea eggs by the end of November then please contact Jo Goodman on 01594 530809 or email her at Jo@ridgewayresearch.co.uk.
To apply for the VTS, you have to have to have been working in your speciality for a minimum of three years, and demonstrate 40-plus hours of RACE-approved CPD.
Before you can sit the exam, you also need to show that you already meet the required standards.
Emily said: “For the application itself, I had to demonstrate mastery of more than 40 advanced nursing skills, signed off by a neurology specialist, and submit three exam questions.
“I submitted more than 60 case logs demonstrating my nursing care in a variety of different patients and disease processes, and four of these logs I further expanded into 10-page case reports where I discussed the nursing care and disease process in more detail.
“Then, after submitting my application, there was a nerve-wracking wait for the results, but last December I received the news I had been accepted and I was invited to sit the examination in Philadelphia, USA, in June.
“The examination was four hours long and consisted of 200 questions in my specialty, and I’m really delighted I passed.
“Neurology is an area that can be quite niche and daunting to those unfamiliar with it, and I hope to use my new qualification to share my knowledge and enthusiasm with other professionals to help them feel more confident and comfortable with these patients.
“Personally, I find nursing neurologic patients extremely rewarding, as there is so much we can do as RVNs which has a direct impact on patient comfort, client understanding and, ultimately, on the clinical outcome.”
Asked why the CMA had decided to launch the review, its Senior Director for Consumer Protection told BBC R4's Today programme this morning that: "the costs of many vet services are rising higher than the cost of inflation, and it can be really hard to find out how much it's going to cost you, both for routine treatments or if something goes wrong and you need to find emergency care for your pet."
George added: "There's many other [veterinary] services and costs that people cannot have predicted and they can find themselves unexpectedly facing some really high bills, and when other household bills are going up very steeply at the moment we want to do everything we can to make sure that people can predict how much it is going to cost to see a vet, both for routine stuff but also for things if there's a crisis."
The authority is also looking at whether there is enough transparency over practice ownership.
With the percentage of independent practices falling from 89% in 2013 to 45% by 2021, the authority says people may not be clear if their vet is part of a group which owns other vet practices in their area or that the services which are being sold to them (such as diagnostic tests or treatments at a specialist animal hospital) are provided by that group.
This, it says, could impact pet owners’ choices and reduce the incentives of local vet practices to compete.
The CMA is now asking veterinary professionals, people who supply veterinary products and services and pet owners to take part in the review by completing an online questionnaire: https://www.gov.uk/guidance/how-to-respond-to-the-veterinary-services-market-for-pets-review
In particular, it wants to hear practitioners' experiences of:
The questionnaire will remain open for six weeks.
The CMA will outline the issues it identifies and announce its next steps early in 2024.
A survey carried out by Intervet/Schering-Plough Animal Health to launch Plerion, a chewable, flavoured wormer for dogs, has shown that most UK dog owners turn to their vet rather than a pet shop for advice on worming.
Over 83% of owners who took part in the survey said they follow their vet's advice on worming whilst fewer than 8% would follow the advice of their local pet shop. 63% choose to buy wormers from their vet against 35% buying wormers from a pet shop or online pharmacy.
Survey participants understood the importance of carrying out a regular worming programme with almost 80% stating that a dog should be wormed every three to four months. However, some owners cited forgetfulness as a reason for not worming their pet regularly and expressed a need for a reminder from their local vet practice.
Almost 85% of those who took part in the survey believed that not all wormers provide the same level of protection and almost 75% said that vet recommendation is the reason they purchase a specific brand of wormer. 94% of owners are aware that worms can affect people as well as dogs.
The survey revealed that 1 in 5 owners experienced difficulty in administering a complete dose due to their dog spitting out part or the entire tablet.
Intervet/Schering Plough says that Plerion should help reduce compliance issues; its innovative and tasty soft chew formulation meaning that most dogs will take it right out of the hand.
Sarah-Jane Minter, marketing manager at Intervet/Schering-Plough said: "When developing Plerion we knew it was essential to launch a product that made life easier for dog owners by being easy, and even fun, to administer as this would increase the likelihood of owners sticking to a regular worming programme. We are delighted by the feedback we are receiving from owners who report their once fussy dogs are taking the flavoured, chewable Plerion tablets as though they were treats."
Plerion is available in two tablet sizes that provide a combination of Pyrantel, Praziquantel and Oxantel which, the company says, gives effective treatment for the major endoparasites in a single dose including tapeworm Echinococcus multilocularis, as required by the Pets Travel Scheme (PETS).
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Pooch & Mutt has 20x 40-day trials of its new joint & bone supplement, Mobile Bones Concentrate, to give away to veterinary professionals.
Guy Blaskey from Pooch & Mutt said: "At The London Vet Show vets and vet nurses told us that they loved the new Mobile Bones Concentrate because at just £9.99 per month it costs less than other joint supplements (whilst having the same high quality ingredients), it takes up a very small amount of shelf space and it doesn't involve the client having to either change their dog's food or stuff pills down their dog's throat."
In response to requests from vets and vet nurses to try the new joint supplement, Pooch & Mutt have set up a dedicated website at www.jointsupplementfordogs.com where you can apply from one of twenty 40 day trials.
Guy continued, "We did not want to simply send samples out to everyone. By setting up the site we can choose a variety of dogs from different breed and with different conditions to send a full 40-day trial to. We hope to get regular feedback from the vets, vet nurses and dog owners involved in the trial and publish it on http://www.jointsupplementfordogs.com/ for everyone else to see."
The trials are available to all veterinary professionals and can be for their own dogs, or dogs belonging to their clients.
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
Eskimo, a reindeer at Edinburgh Zoo has received life-saving surgery just in time for Christmas, making him the first reindeer in history to receive keyhole surgery.
Vet Romain Pizzi successfully removed one of Eskimo's testes, which had been lodged in its abdomen since birth, using specialist surgical instruments donated to the zoo by one of Ark Surgical's strategic partners Surgical Innovations.
The zoo was worried that the retained testicle may have been developing into a tumour giving off abnormal hormones, and that this could become life-threatening. Thankfully, zoo surgeons found that the retained testicle, although abnormally sized, had not yet developed a tumour.
It is thought that the abnormal testicle was affecting Eskimo's production and flow of testosterone and, as a result, he was showing submissive behaviour and being bullied by the other male reindeer in the herd. He had also started to show some abnormal and delayed antler growth and development. Removing the testicle will halt any abnormal hormone production so hopefully Eskimo will return to full vigour just in time for Christmas.
Gavin O'Brien, Director at Ark Surgical said: "We were only too happy to help when Romain mentioned the challenging operation faced by Eskimo and in the season of goodwill we approached Surgical Innovations who kindly donated the instruments for this pioneering surgery."
Although laparoscopic surgery is routine in humans, the standard procedure in animals is still open abdominal surgery. Open abdominal surgery is 20 years behind human medical advances and has a number of negative factors on animals such as more post-operative pain, slower recovery and a higher risk of post-operative complications and infections.
Romain, a veterinary surgeon for the Royal Zoological Society of Scotland, based at Edinburgh Zoo, said: "Laparoscopic surgery is still very uncommon in veterinary medicine, even amongst common species such as dogs, cats and horses, so for keyhole surgery to be carried out on a reindeer shows a great advancement in veterinary surgery."
It is estimated that nearly one out of every two households in the UK are pet owners. Veterinary surgeons perform on average 600,000 open abdominal procedures annually but it is believed that less than 1% of vets currently practice laparoscopic surgery.
Romain believes that with the right instrumentation available through innovative companies such as Ark Surgical, UK vets now have more opportunity than ever to introduce laparoscopic techniques as part of their operating procedures.
Romain said: "This procedure was only really possible thanks to a cutting-edge designed retractor which we were able to use in this case. Ironically although a reindeer is a reasonably large animal, due to their unique anatomy and massive four chambered stomach that takes up most of the space in the abdomen, there is a very limited internal operating space. For this reason the operation was much more difficult than in a human, or in a dog, where there is more space to work, despite their smaller size."
"We were especially pleased with how quickly Eskimo recovered after surgery, he was standing and happily eating lichen again within 10 minutes of recovery from anaesthesia. He hardly seemed to notice he had even had surgery, although he was still slightly groggy from the anaesthesia. This would simply not have been possible with traditional open abdominal surgery, as the long wound would have been much more painful and debilitating."
The minimally invasive nature of laparoscopic surgery means there are numerous benefits for animals such as a reduction in post-operative pain, a faster recovery and reduced post-operative care. It also has a decreased risk of infection after surgery and a lower risk of any wound complications.
For veterinary surgeons laparoscopic surgery can offer better visualisation of the operated area, allowing them to be more precise and reach areas that are difficult to see in open surgery such as the liver and pelvic canal.
Romain carries out laparoscopic operations on dogs, cats and exotic pets at his own veterinary practice Inglis Veterinary Centre (Scotland) and has pioneered several new laparoscopic techniques.
He said: "Laparoscopic surgery has so many benefits for the animal, the veterinary surgeons and the zoo, so there is no reason why it should not be more common practice within veterinary surgery. I hope Eskimo's experience helps raise its profile and encourage more veterinary surgeons to look in to it as a standard surgical procedure."
Ark Surgical offers a wide range of laparoscopy instruments and peripherals to vets across the UK and to suit all budgets. The company says it is already working with many of the UK's leading vets and agencies such as the Royal Zoological Society of Scotland, as well as the UK foremost laparoscopic medical device manufacturer Surgical Innovations, to be at the forefront of veterinary laparoscopic surgery
For more information on animal laparoscopic surgery contact Ark Surgical on 01732 862882 or http://www.arksurgical.co.uk/
The RCVS Trust will take part in National Pet Month (3 April - 3 May) and is asking veterinary practices to put on 'Alice in Wonderland' themed fundraising events.
Cherry Bushell, RCVS Trust Director said: "The Trust aims to improve the health and well-being of dogs, cats, and other popular household pets and over the past five years has put nearly £900,000 into this cause. As a small charity we do rely on our supporters - and National Pet Month is a good opportunity to raise money and have fun."
Why Alice in Wonderland as a theme? Cherry said: "The Trust supports curiosity and a sense of wonder, so we came up with the Alice in Wonderland idea - which is topical and also has lots of scope for fundraising and publicity."
If you'd enjoy hosting a Mad Hatter's tea party - or raffling off the Queen of Heart's tarts - you can register with National Pet Month and take part. Further information and a free events pack can be obtained from http://www.nationalpetmonth.org.uk/.
National Pet Month runs from 3 April - 3 May. It aims to promote responsible pet ownership, make people aware of the mutual benefits of living with pets, increase public awareness of the role of pet care specialists and raise awareness of the value of working and assistance companion animals.
Rabbit Awareness Week (26th April - 2nd May 2010) is reportedly going to be bigger than ever this year with over 1000 vets within the industry expected to be involved.
In partnership with Burgess Pet Care, Petplan Insurance, Company of Animals, Intervet/Schering-Plough Animal Health, Genitrix, PDSA, Wood Green Animal Shelters and RWAF, Rabbit Awareness Week's mission is to educate current and potential rabbit owners across the UK about the importance of rabbit welfare.
The focus of the week will be rabbit obesity. At the same time, organisers hope the week will raise the profile of rabbits as pets and encourage owners to seek the right veterinary advice about rabbit nutrition and health.
The week has been deliberately timed to happen soon after Easter, to make use of a time of year when rabbits are at the forefront of people's minds. Organisers hope to reach rabbit owners who may have bought new pet rabbits but who may not have the right information about how to keep them happy and healthy.
Throughout the week some of the UK's largest retailers, suppliers of rabbit food and welfare charities will be providing valuable feeding knowledge and information, along with a range of deals and offers to vets and pet owners.
Organisers are asking veterinary practices to get involved by offering Free Health Checks for pet rabbits, and by providing free advice about vaccinations, husbandry and diet. To help, there is a range of display and training materials to help you run your Free Health Checks together with promotional materials such as newsletter templates and press releases. You can also register your event for free on the Online Event Locator.
The display kit includes shelf wobblers, barkers, posters, appointment flyers, Health Check Certificates and an A3 size Free Health Check window sticker. You'll also receive additional items to give away to rabbit owners, including Excel samples, RAW care guides, car stickers and branded bags.
For more information and to find out what special trade offers are available to vets during the week register at http://www.rabbitawarenessweek.co.uk/.
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
Novartis Animal Health's year long campaign to drive pet-owner awareness of the importance of worming pets regularly got off to a rather damp start in London today, with 63 people in doggy suits - mostly company employees I gather - running around the capital accompanied by two 'pooch vans'.
The 'Worm Patrol' team will be visiting veterinary practices over the summer to help promote, set up and run Pet Worming Awareness Days and attend practice open days. Veterinary practitioners will have access to the Worm Patrol support kit including the branded pooch van, Chewy the dog mascot and a worm patrol ambassador. Additional support will include educational leaflets for owners, giveaways and waiting room materials.
Maggie Fisher, Chairperson of the European Scientific Counsel for Companion Animal Parasites is backing the campaign. She said: "Raising awareness of worm control throughout the life of cats and dogs is important, particularly when it is reported that 80 percent of children kiss their pet and 21 percent let them lick their fingers after sharing food. While the risk may be relatively low, the consequences can be serious, especially in children.
"It's important that pet owners take responsibility for their animals and we are pleased that initiatives such as the Worm Patrol and 'Pet Worming Awareness Days' will help practices highlight the risk that endoparasites pose to humans and companion animals in a novel and light-hearted way."
To arrange for the Worm Patrol to visit to your practice, or for further information about setting up a Pet Awareness Worming Day, please contact your Novartis Animal Health Territory Manager or Novartis Animal Health UK Ltd on +44 (0)1276 694402.
The RCVS is to embark on a communications campaign over the next few months to raise awareness amongst the general public of the difficulties that vets face in providing out-of-hours emergency cover, and the responsibilities incumbent on animal owners to know what to do in a veterinary emergency.
Emergency cover has been high on the College's agenda for some time.
Over the last 18 months, the RCVS 24/7 Working Party has considered the ongoing desire of vets to continue to offer emergency care 24 hours a day, and the feasibility of delivering this, against a backdrop of the Working Time Regulations, geographical variations in animal and vet density, and increasing practice diversity.
Working Party meetings have been supported by a survey of how vets are currently meeting their 24/7 requirements, a seminar of stakeholders and regular informal polls at RCVS Question Time meetings.
It was agreed at the September 2009 meeting of Advisory Committee, to which the Working Party reports, that the majority of vets remain willing to deliver emergency cover 24/7. Advisory Committee recommended that a communications project be undertaken to help raise awareness amongst the general public and animal owners that although the veterinary profession continues to make this voluntary commitment, EU rules, geography and financial constraints impose some limitations.
This campaign will kick off soon and focus on spreading messages via animal-owner publications and websites. The responsibility of pet owners to know how they can access emergency care for their animal in advance of need will be stressed, as will the fact that in the absence of an NHS for pets, emergency care is a service for which practices must charge a realistic fee (which is likely to be higher than for day-time work).
The campaign will also outline vets' responsibilities as part of the Guide, so the public knows what it can reasonably expect. It would be helpful if practices could ensure they have clear information available on their 24/7 arrangements - as outlined in the Guide - should this campaign stimulate requests from clients.
Jerry Davies, who chaired the Working Party, said: "There is overwhelming opinion within the profession that we must continue to provide round-the-clock veterinary care. The main tenet of the Working Time Regulations is that workers should not have their health or, importantly, skills compromised by unreasonable working patterns. Vets, VNs and the animals they care for deserve the same level of protection.
"However, this legislation has made continuing to provide such care at a reasonable cost to the animal owner a significant challenge. Meeting this challenge will require the understanding and cooperation of the animal owning public.
"If clients can be flexible and accept slightly longer response times, an effective service can still be sustained. The key is for all animal owners to establish, in advance, exactly what will be involved should they need to access veterinary care in an emergency. This simple step will help optimise response times and eliminate the frustration, confusion and inevitable dissatisfaction that may arise if ill-prepared."
Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%1, owner observed improvements in clinical signs3, and improved weight bearing ability2, 7
The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis 1, 2,3.
According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase1. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced4. High levels of omega-3 fatty acids can also help to reduce inflammation5,6.
The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.
In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing2. Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.
In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition3. Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.
Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly."
For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.
References1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-733. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-664. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-195. Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-3586. Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S7. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.
The CVS practice aimed to change its prescribing culture by adopting an evidence-based, case-by-case approach and supporting its vets in only using antibiotics where absolutely necessary.
The practice identified the use of antibiotics in the treatment of cat bite abscesses (CBAs) as worthy of investigation.
Cefovecin, a third-generation cephalosporin and critically important antibiotic, is often used in the treatment of CBAs.
The practice first sought guidance from a dermatology specialist with an active research programme involving the study of antimicrobial resistance (AMR).
It then developed a clinical guideline advising that if a cat has a discrete abscess, with no pyrexia (raised temperature) and no cellulitis, antibiotics are not required.
White Lodge then conducted an eight-month clinical audit across its Exmouth Hub, with the aim of measuring the effect of the new guideline.
The practice treated patients with CBA’s with NSAIDS, lancing and flushing (if necessary), and cleaning of the abscess.
Owners were advised to flush the affected area at home once daily.
An antibiotic awareness leaflet was given to clients with an explanation of the reasoning behind not prescribing antibiotics.
Cats presented 5-7 days after treatment for a nurse re-examination.
A consultation template was created for both the vet at initial presentation and another for the nurse’s post treatment check, to gather standardised information.
The measure of successful treatment was whether, on re-examination, the CBA site appeared free from infection and wound healing was evident.
If the wound had not started to heal or if there was infection or pyrexia, the treatment was deemed to have failed and further treatment was provided.
Analysis of the results showed that of the 22 cats included in the audit, 19 (86%) did not need antibiotics to successfully treat the abscess.
There was also a 32.6% reduction in the number of times cefovecin was dispensed in the eight-month period after the audit started, compared with the previous eight months.
Emily Parr, Head Veterinary Surgeon at White Lodge, said: “We think, due to lack of confidence in treatment without antibiotics as well as client pressure or expectation, the profession tends to default to the prescribing of antibiotics.
“However, this clinical audit has given our veterinary colleagues increased confidence in treating CBA’s without antibiotics.
"There has also been an improved client understanding in accepting treatment without antibiotics.
"Clients have also been positive when minimal intervention has been required, particularly as it eliminates the cost of antibiotics.
"This has had a positive impact on the vet-client relationship and trust in our practice.
“Antimicrobial resistance is continuing to threaten the efficacy and treatment of an ever-increasing range of infections.
"So we hope that our CBA clinical audit outcome results will help to set a benchmark and shape clinical guidelines for the wider veterinary profession in this area.”
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.
Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.
The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures. The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.
Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system. Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs.
Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.
Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years. The main problem has been that it's not been licensed as a medicine. With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical. We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."
Howard Wilder, founder and managing director of Genitrix, added: "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK. It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.
We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide. We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."
Broadline was a fipronil-based parasiticide which also contained (S)-methoprene, eprinomectin and praziquantel.
NexGard Combo, on the other hand, contains esafoxolaner together with eprinomectin and praziquantel for worming.
Both products are licensed for use in cats with or at risk from mixed infestations by fleas, ticks, mites cestodes, nematodes.
There's an explainer video about NexGard Combo on the Boehringer Academy website: https://www.boehringer-academy.co.uk/